title: Clinical protein science developments for patient monitoring in hospital central laboratories.
abstract: Patient care relies heavily on standardized tests performed in hospital laboratories, typically including clinical chemistry, pathology and microbiology. With the introduction of personalized medicine tremendous efforts have been made to identify new biomarkers of disease with various omics technologies, often including mass spectrometry. In order to validate new biomarkers and perform clinical studies high quality biobank samples are of key importance. In this editorial different aspects of mass spectrometry in future personalized medicine are discussed.
authors.affiliation: Department of Translational Medicine, Section for Clinical Chemistry, Lund University, Skåne University Hospital Malmö, 205 02, Malmö, Sweden.|Center of Excellence in Biological and Medical Mass Spectrometry, Lund University, BMC D13, 22100, Lund, Sweden.|Clinical Protein Science & Imaging, Biomedical Center, Department of Biomedical Engineering, Lund University, BMC D13, 221 84, Lund, Sweden.
authors.forename: Johan
authors.initials: J
authors.lastname: Malm
authors.affiliation: Center of Excellence in Biological and Medical Mass Spectrometry, Lund University, BMC D13, 22100, Lund, Sweden. Gyorgy.MarkoVarga@BME.lth.SE.|Clinical Protein Science & Imaging, Biomedical Center, Department of Biomedical Engineering, Lund University, BMC D13, 221 84, Lund, Sweden. Gyorgy.MarkoVarga@BME.lth.SE.|First Department of Surgery, Tokyo Medical University, 6-7-1 Nishishinjiku Shinjiku-ku, Tokyo, 160-0023, Japan. Gyorgy.MarkoVarga@BME.lth.SE.
authors.forename: György
authors.initials: G
authors.lastname: Marko-Varga
keywords: Assay; Biomarker; Mass spectrometry; Proteomics